Increasepharm (Hengqin) Institute Co., Ltd.  was established on January 4, 2017 and located in Zhuhai Hengqin New District, Guangdong-Macao Cooperation TCM Technology Industrial Park, where has an existing R&D office space of 1,200 square meters. The company can rely on the advantages of Guangdong-HongKong-Macao Greater Bay Area (GBA) policy, the national buttressing TCM policy and the developing of the biomedical health industry in GBA. With this, the company is more efficient and comprehensive develop TCM, which aims to promote the exchange and cooperation of TCM in countries along with the "Belt and Road" policy, enhance the international influence of TCM health services as well.

The company's main service scope includes new drug, new preparation, international contract research, international food and drug import and export registration, international biomedical training and international pharmaceutical and food quality inspection, etc. At the same time, two government-level scientific research platforms have been established, the New Drug Delivery System Sub-center of the National Chinese Medicine Modernization Engineering Technology Research Center and the Guangdong Aerosol Inhalation Preparation Engineering Technology Research Center.